Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012 (2012), Article ID 747658, 5 pages
http://dx.doi.org/10.1155/2012/747658
Case Report

Bilateral Simultaneous Nonarteritic Anterior Ischemic Optic Neuropathy after Ingestion of Sildenafil for Erectile Dysfunction

Department of Ophthalmology, University of Udine, 33100 Udine, Italy

Received 25 November 2011; Accepted 9 January 2012

Academic Editor: Gianfranco D. Alpini

Copyright © 2012 Anna Tarantini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. W. Fraunfelder, “Visual side effects associated with erectile dysfunction agents,” American Journal of Ophthalmology, vol. 140, no. 4, pp. 723–724, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. P. O'Malley, “Viagra and vision loss: what is known and unknown,” Clinical Nurse Specialist, vol. 20, no. 5, pp. 227–228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Calvet, K. Martin, G. Robert et al., “Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN),” Progres en Urologie, vol. 17, no. 5, pp. 920–927, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. M. El-Domyati, H. M. El-Fakahany, and K. E. Morad, “Nonarteritic ischaemic optic neuropathy (NAION) after 36 h of intake of sildenafil citrate: First Egyptian case,” Andrologia, vol. 41, no. 5, pp. 319–321, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. F. Azzouni and K. Abu samra, “Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? a critical analysis and review of the literature,” Journal of Sexual Medicine, vol. 8, no. 10, pp. 2894–2903, 2011. View at Publisher · View at Google Scholar · View at PubMed
  6. T. Felekis, I. Asproudis, K. Katsanos, and E. Tsianos, “A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil,” Clinical Ophthalmology, vol. 5, no. 1, pp. 1443–1445, 2011. View at Google Scholar
  7. MM Moschos and I. Margetis, “Bilateral simoultaneous anterior ischemic optic neuropathy associated with sildenafil,” Case Reports in Ophthalmology, vol. 2, no. 2, pp. 262–265, 2011. View at Google Scholar
  8. M. Beri, M. R. Klugman, J. A. Kohler, and S. S. Hayreh, “Anterior ischemic optic neuropathy: VII. Incidence of bilaterality and various influencing factors,” Ophthalmology, vol. 94, no. 8, pp. 1020–1028, 1987. View at Google Scholar · View at Scopus
  9. N. J. Newman, R. Scherer, P. Langenberg et al., “The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study,” American Journal of Ophthalmology, vol. 134, no. 3, pp. 317–328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Shibayama, H. Oku, Y. Imamura, S. Kajiura, J. Sugasawa, and T. Ikeda, “Bilateral, nearly simultaneous anterior ischemic optic neuropathy complicated by diabetes and bilateral, small, crowded optic discs,” Japanese Journal of Ophthalmology, vol. 49, no. 3, pp. 235–238, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. Y. Chuang, J. Y. Guh, K. A. Wang, Y. J. Huang, and J. S. Huang, “Role of nitric oxide in high glucose-induced mitogenic response in renal fibroblasts,” Molecular Endocrinology, vol. 20, no. 10, pp. 2548–2558, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. H. Kimura and H. Esumi, “Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis,” Acta Biochimica Polonica, vol. 50, no. 1, pp. 49–59, 2003. View at Google Scholar · View at Scopus
  13. A. Sparatore, G. Santus, D. Giustarini, R. Rossi, and P. Del Soldato, “Therapeutic potential of new hydrogen sulfide-releasing hybrids,” Expert Review of Clinical Pharmacology, vol. 4, no. 1, pp. 109–121, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. Y. Mikami, N. Shibuya, Y. Kimura, N. Nagahara, M. Yamada, and H. Kimura, “Hydrogen sulfide protects the retina from light-induced degeneration by the modulation of Ca2+ influx,” Journal of Biological Chemistry, vol. 286, no. 45, pp. 39379–39386, 2011. View at Publisher · View at Google Scholar · View at PubMed
  15. P. Quiram, S. Dumars, B. Parwar, and D. Sarraf, “Viagra-associated serous macular detachment,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 243, no. 4, pp. 339–344, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus